PCSK9 and familial hypercholesterolemia: Mutations of PCSK9 have been recognized as genetic markers of familial hypercholesterolemia (FH), whereas lower levels of LDL-C, as well as reduced risk of coronary heart diseases, were found in those with loss-of-function mutations [13].